Man With Hemophilia A Treated for COVID-19 While on Hemlibra

Man With Hemophilia A Treated for COVID-19 While on Hemlibra

296453

Man With Hemophilia A Treated for COVID-19 While on Hemlibra

A 70-year-old man with severe hemophilia A was treated for COVID-19 while receiving prophylactic, or preventive, treatment with Hemlibra (emicizumab) to lower his bleeding risk. This case underscores the importance of close cooperation between physicians of many specialties and appropriate treatment to avoid blood clots, while maintain blood clotting factors within a normal range, its investigators reported. “The case presented here is, to our knowledge, the first in the literature documenting successful evolution of severe…

You must be logged in to read/download the full post.